<DOC>
	<DOCNO>NCT01243983</DOCNO>
	<brief_summary>The primary objective study assess safety efficacy voclosporin therapy subject active noninfectious uveitis involve intermediate and/or posterior segment eye ( i.e. , anterior + intermediate- , intermediate- , posterior- pan-uveitis ) .</brief_summary>
	<brief_title>Efficacy Safety Voclosporin Treat Active Noninfectious Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<criteria>Active noninfectious uveitis involve intermediate and/or posterior segment ( i.e. , anterior + intermediate , intermediate , posterior panuveitis ) least one eye evidence vitreous haze grade least 2+ baseline visit . Subjects also anterior segment involvement need exclude otherwise qualify . Subjects must : Capable understand purpose risk study . Able give write informed consent . Able comply study requirement . Ocular Disease/Conditions The following condition exclusionary present : Uveitis limit anterior segment study eye . Confirmed suspect infectious uveitis either eye . Prior Current Treatment : As define protocol Extraocular Conditions : As define protocol . Laboratory , Blood Pressure ECG Evaluations : As define protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>